Emerging therapies for relapsing multiple sclerosis

Arch Neurol. 2009 Jul;66(7):821-8. doi: 10.1001/archneurol.2009.104.


Six agents are currently approved by regulatory agencies to treat relapsing multiple sclerosis. Although these agents are effective and generally safe, some patients have continued disease activity or adverse effects. A sizable number of new agents are under investigation currently. This article reviews emerging agents that have shown promise in phase 2 trials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Clinical Trials as Topic
  • Emergency Treatment / methods*
  • Enzyme Inhibitors / therapeutic use
  • Estriol / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Multiple Sclerosis, Chronic Progressive / drug therapy*


  • Enzyme Inhibitors
  • Immunologic Factors
  • Estriol